Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?

被引：0
作者：
Safavi, Amir H. [1 ]
Palma, David A. [2 ]
Giuliani, Meredith E. [1 ,3 ]
机构：
[1] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[2] London Hlth Sci Ctr, Dept Radiat Oncol, London, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 05期
关键词：
RADIOTHERAPY; RISK; SBRT;
D O I：
10.1016/j.ijrobp.2023.08.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1232 / 1235
页数：4
相关论文
共 38 条
[31]   How can we define and analyse drug exposure more precisely to improve the prediction of hospitalizations in longitudinal (claims) data? [J].
Meid, Andreas D. ;
Groll, Andreas ;
Schieborr, Ulrich ;
Walker, Jochen ;
Haefeli, Walter E. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (03) :373-380
[32]   How Can We Improve Osteoporosis Care? A Systematic Review and Meta-Analysis of the Efficacy of Quality Improvement Strategies for Osteoporosis [J].
Nayak, Smita ;
Greenspan, Susan L. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (09) :1585-1594
[33]   The preventive treatment of recurrent stone-formation: how can we improve compliance in the treatment of patients with recurrent stone disease? [J].
Kok, Dirk Jan .
UROLITHIASIS, 2016, 44 (01) :83-90
[34]   How can we differentiate supratentorial tumor recurrence from postradiation imaging changes in children treated for primary malignant brain tumors? [J].
Zittoun, Jacob ;
Dangouloff-Ros, Volodia ;
Cardoen, Liesbeth ;
Rutten, Caroline ;
Bolle, Stephanie ;
Alapetite, Claire ;
Levy, Raphael ;
Grevent, David ;
Grill, Jacques ;
Brisse, Herve J. ;
Doz, Francois ;
Blauwblomme, Thomas ;
Beccaria, Kevin ;
Charpy, Sarah ;
Roux, Charles-Joris ;
Varlet, Pascale ;
Dufour, Christelle ;
Puget, Stephanie ;
Boddaert, Nathalie .
JOURNAL OF NEUROSURGERY-PEDIATRICS, 2023, 32 (02) :173-183
[35]   Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes [J].
Isles, Mike .
INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2020, 31 (03) :133-144
[36]   How Can We Improve Online HIV and STD Prevention for Men Who Have Sex with Men? Perspectives of Hook-Up Website Owners, Website Users, and HIV/STD Directors [J].
Wohlfeiler, Dan ;
Hecht, Jennifer ;
Volk, Jonathan ;
Raymond, H. Fisher ;
Kennedy, Tom ;
McFarland, Willi .
AIDS AND BEHAVIOR, 2013, 17 (09) :3024-3033
[37]   How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines? [J].
Mark, Laszlo ;
Paragh, Gyoergy ;
Karadi, Istvan ;
Reiber, Istvan ;
Pados, Gyula ;
Kiss, Zoltan .
ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (04) :608-613
[38]   What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial [J].
Sayar, Zara ;
Czuprynska, Julia ;
Patel, Jignesh P. ;
Benjamin, Reuben ;
Roberts, Lara N. ;
Patel, Raj K. ;
Cornelius, Victoria ;
Arya, Roopen .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) :315-322
1234